UNLIMITED FREE
ACCESS TO THE WORLD'S BEST IDEAS

SUBMIT
Already a GlobalSpec user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your GlobalSpec Experience

Select Your Free Newsletters

Industry Newsletters

Select Your Free Product Alerts

Finish!
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

ISO 22442-2 FRENCH

Dispositifs médicaux utilisant des tissus animaux et leurs dérivés - Partie 2: Contrôles de l'origine, de la collecte et du traitement

inactive
Buy Now
Organization: ISO
Publication Date: 15 December 2007
Status: inactive
Page Count: 24
ICS Code (Biological evaluation of medical devices): 11.100.20

Document History

ISO 22442-2 FRENCH
September 1, 2020
Dispositifs médicaux utilisant des tissus animaux et leurs dérivés — Partie 2: Contrôles de l'origine, de la collecte et du traitement
A description is not available for this item.
ISO 22442-2 FRENCH
November 1, 2015
Dispositifs médicaux utilisant des tissus animaux et leurs dérivés - Partie 2: Contrôles de l’origine, de la collecte et du traitement
A description is not available for this item.
ISO 22442-2 FRENCH
December 15, 2007
Dispositifs médicaux utilisant des tissus animaux et leurs dérivés - Partie 2: Contrôles de l'origine, de la collecte et du traitement
A description is not available for this item.

References

This document is referenced by:
SN EN ISO 22442-3 - Medical devices utilizing animal tissues and their derivatives - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents
Published by SNV on March 1, 2008
This part of ISO 22442 specifies requirements for the validation of the elimination and/or inactivation of viruses and TSE agents during the manufacture of medical devices (excluding in vitro...
This document is referenced by:
ISO TR 22442-4 - Medical devices utilizing animal tissues and their derivatives — Part 4: Principles for elimination and/or inactivation of transmissible spongiform encephalopathy (TSE) agents and validation assays for those processes
Published by ISO on December 1, 2010
This Technical Report offers suggestions for designing and conducting validation assays to help determine if processes used in the manufacture of medical devices derived from non-viable animal...
This document is referenced by:
EN ISO 13408-5 - Aseptic processing of health care products - Part 5: Sterilization in place
Published by CEN on June 1, 2011
This part of ISO 13408 specifies the general requirements for sterilization in place (SIP) applied to product contact surfaces of the equipment used in the manufacture of sterile health care products...
This document is referenced by:
ISO 13022 - Medical products containing viable human cells - Application of risk management and requirements for processing practices
Published by ISO on April 1, 2012
This International Standard specifies requirements and guidance for processing practices and managing risk associated with viable cellular components of products regulated as medicinal products,...
This document is referenced by:
SN EN ISO 14937 - Sterilization of health care products - General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices
Published by SNV on March 1, 2010
Inclusions This International Standard specifies general requirements for the characterization of a sterilizing agent and for the development, validation and routine monitoring and control of a...
View Less
View All
Advertisement